Skip Navigation

Lupus Research Alliance

Stories & News

Positive Results of Phase 3 Dapirolizumab Pegol Trial in Systemic Lupus Erythematosus Shown in Published Paper

The Lupus Research Alliance welcomes additional positive results from the Phase 3 PHOENYCS GO study showing that combined with standard care, investigational dapirolizumab pegol (DZP) in...

Introducing the “Hope in Action” Fireside Chat Series

Watch Episode 1 On Demand Here Progress in lupus research is accelerating, bringing new momentum, new possibilities, and new hope...

Nancy Mize Gonzalez: Putting Passion into Action

Nancy Mize Gonzalez did not set out to build a career around lupus. She set out to follow her...

LRA Progress & Purpose Update | Albert T. Roy – May 2026

Hear from President and CEO Albert T. Roy as he recaps the organization’s activations from Lupus Awareness, shining a...

Learning About Lupus in the Asian American & Pacific Islander Populations

May marks Lupus Awareness Month – but it is also a month to honor Asian American and Pacific Islander...

Tell Congress Why Lupus Research Funding Must be a Priority

With your help, the Lupus Research Alliance has become the world’s largest funder of lupus research. The Lupus Research...

House Appropriations Committee Supports Lupus ABC

Great news! With a unanimous, bipartisan vote, the House Appropriations Committee adopted a provision supporting the Lupus Accelerating Breakthroughs...

Letter from LRA President & CEO Albert T. Roy

Dear Friends, Lupus Awareness Month begins today, and with it comes a renewed sense of purpose, momentum, and possibility. Thanks...

Saphnelo™ Approved as Self-Administered Autoinjector

The U.S. Food and Drug Administration just granted approval for a self-administered, once-weekly autoinjector of Saphenlo (anifrolumab), for the treatment of adult patients...

Debbie Schwartz: Advocating in Every Sense of the Word

Debbie Schwartz is absolutely convinced that a cure for lupus will be found in her lifetime. Why? Because she’s done something like this once before. Debbie previously dealt with epileptic...

New Findings from Lupus Research Alliance-Funded Researcher Links Common Gut Bacteria to Lupus Flares

LRA-funded researcher Gregg Silverman, MD, NYU Grossman School of Medicine, is the lead author on a new study published...

FDA Accepts Application for Gazyva® (obinutuzumab) to Treat SLE

The U.S. Food and Drug Administration has accepted the supplemental Biologics License Application from Genentech for Gazyva® (obinutuzumab) to treat systemic lupus erythematosus (SLE), the most common form of...